Acarix
Brief
Acarix is a Swedish medical device company that innovates solutions for rapid risk stratify of coronary artery disease (CAD) at point of care.
Profile
The CE-approved and FDA DeNovo-cleared Acarix CADScor System is intended for patients experiencing chest pain with suspected CAD and designed to help reduce millions of unnecessary, invasive, and costly diagnostic procedures.
The CADScor System has been used on more than 40,000 patients.3 Acarix recommends CADScor System as a first-line diagnostic aid that uses highly sensitive acoustics and computational processing to analyze coronary blood flow to risk stratify significant coronary artery disease (CAD), with at least 96% certainty at point of care.
Headquarters